Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Calling all vaccinators: Closing the next gap in Covid supply and demand

Beating back Covid right now comes down to balancing supply and demand.

23 Feb 2021

More diverse SARS-CoV-2 variants identified within infected children than in adults

A new study describes the identification of multiple circulating variants of SARS-CoV-2 during this early pandemic period from Asia and Europe. In addition, there were multiple local introductions of different variants, that resulted in multiple waves of transmission.

23 Feb 2021

What makes viruses infectious?

In this interview, News-Medical spoke to Professor Peter Stockley about his latest research that looked at what makes viruses infectious.

23 Feb 2021

Three studies emphasize how behavioral and social factors are intrinsic to aging

A trio of recent studies highlights the need to incorporate behavioral and social science alongside the study of biological mechanisms in order to slow aging.

23 Feb 2021

Influenza A virus defective interfering particles against SARS-CoV-2

In the search for a broadly acting pan-specific antiviral, an interdisciplinary team from Germany tested the previously proposed (for antiviral treatment against Influenza A infections) - Influenza A virus (IAV) defective interfering particles (DIPs). The research is published online on the bioRxiv preprint server.

23 Feb 2021

CovMT could help researchers to track evolution of SARS-CoV-2 mutations

A SARS-CoV-2 tracker uses publicly available sequencing data to show how the virus is changing and spreading over time. The tracker, called CovMT, was developed at KAUST and is expected to help researchers and policymakers understand the evolution of the virus's mutations.

22 Feb 2021

Virus-specific cellular immunity may be essential for long-term protection against SARS-CoV-2

Researchers from China and the US recently synthesized select peptide pools of the structural and functional proteins of SARS-CoV-2, including spike (S), envelope (E), membrane (M), nucleocapsid (N), and protease (P) proteins as target antigens to assess COVID-19-specific immunity.

22 Feb 2021

WVU researchers set to identify SARS-CoV-2 variants, mitigate strain outbreaks

West Virginia University scientists knew it was coming. When health officials confirmed the first three cases of a COVID-19 variant in West Virginia late Friday (Feb. 19), they were not surprised.

22 Feb 2021

Toddler sleep habits could help explain the association between household poverty and BMI

Establishing a consistent sleep schedule for a toddler can be one of the most challenging aspects of child rearing, but it also may be one of the most important.

22 Feb 2021

Failed antiviral response in nasal mucosa may predict severe COVID-19

Researchers in the United States have conducted a study suggesting that the host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within nasal mucosa is a key determinant of clinical trajectory in coronavirus disease 2019 (COVID-19).

22 Feb 2021

FDA issues guidance for medical product developers to address the emergence of SARS-CoV-2 variants

Today, the U.S. Food and Drug Administration issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes COVID-19.

22 Feb 2021

An overview of spike protein antigen COVID-19 vaccine candidates

A new paper in the journal Reviews in Medical Virology provides a perspective on current vaccine development strategies and tools, which may allow the production of safe and effective vaccines.

22 Feb 2021

Some nutritional supplements may help prevent or mitigate COVID-19 severity

A new study in the Journal of dietary supplements shows that nutritional supplements, including several vitamins and the mineral zinc, may be useful in preventing the infection or reducing its severity if caught.

22 Feb 2021

Human monoclonal antibodies can act as a substitute for traditional antibiotics

In the course of a new and groundbreaking study, led by Dr, Natalia Freund and the doctoral candidate Avia Waston at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal antibodies, which hindered the growth of tuberculosis germs in laboratory mice. The

22 Feb 2021

Organ transplant patient dies after receiving Covid-infected lungs

Doctors say a woman in Michigan contracted covid-19 and died last fall two months after receiving a tainted double-lung transplant from a donor who turned out to harbor the virus that causes the disease — despite showing no signs of illness and initially testing negative.

22 Feb 2021

Long-term exposure to air pollution can increase cardiovascular and respiratory risks

Exposure to what is considered low levels of air pollution over a long period of time can increase the risk of heart attack, stroke, atrial fibrillation, and pneumonia among people ages 65 and older, according to new research published today in the American Heart Association's flagship journal Circulation.

22 Feb 2021

SARS-CoV-2 DNA vaccine tested in animal model

A team of experts has tested the immune responses elicited by mucosal homologous plasmid and a heterologous immunization strategy using a plasmid vaccine and a Modified Vaccinia Ankara (MVA) expressing SARS-CoV-2 spike (S) and nucleocapsid (N) antigens.

21 Feb 2021

Cissampelos pareira L. extracts demonstrate anti-SARS-CoV-2 activity in vitro

A team of scientists from India has recently investigated the antiviral potency of a traditional medicinal plant Cissampelos pareira L. in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The findings reveal that both whole-plant extracts and bioactive compounds can inhibit SARS-CoV-2 replication by modulating estrogen receptor 1 (ESR1) activity.

21 Feb 2021

Interval between doses of Oxford COVID-19 vaccine can be safely extended to 3 months, suggests study

A 3-month interval between doses of the Oxford COVID-19 vaccine results in higher vaccine efficacy than a 6-week interval, with the first dose offering 76% protection in the 3 months between doses.

20 Feb 2021

Antimicrobial resistance to critical drugs spirals in low- and middle-income countries

As antibiotic use grows in lower-income countries so does antibiotic resistance, says report.

20 Feb 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Calling all vaccinators: Closing the next gap in Covid supply and demand

More diverse SARS-CoV-2 variants identified within infected children than in adults

What makes viruses infectious?

Three studies emphasize how behavioral and social factors are intrinsic to aging

Influenza A virus defective interfering particles against SARS-CoV-2

CovMT could help researchers to track evolution of SARS-CoV-2 mutations

Virus-specific cellular immunity may be essential for long-term protection against SARS-CoV-2

WVU researchers set to identify SARS-CoV-2 variants, mitigate strain outbreaks

Toddler sleep habits could help explain the association between household poverty and BMI

Failed antiviral response in nasal mucosa may predict severe COVID-19

FDA issues guidance for medical product developers to address the emergence of SARS-CoV-2 variants

An overview of spike protein antigen COVID-19 vaccine candidates

Some nutritional supplements may help prevent or mitigate COVID-19 severity

Human monoclonal antibodies can act as a substitute for traditional antibiotics

Organ transplant patient dies after receiving Covid-infected lungs

Long-term exposure to air pollution can increase cardiovascular and respiratory risks

SARS-CoV-2 DNA vaccine tested in animal model

Cissampelos pareira L. extracts demonstrate anti-SARS-CoV-2 activity in vitro

Interval between doses of Oxford COVID-19 vaccine can be safely extended to 3 months, suggests study

Antimicrobial resistance to critical drugs spirals in low- and middle-income countries

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in